StockData
ArriVent BioPharma, Inc. logo

ArriVent BioPharma, Inc. (AVBP) KPIs and segments

AVBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$10.69−0.87 (-7.53%)

Close on Nov 17, 2026Market cap $527.10MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive ArriVent BioPharma's business

Coming soon

This tab will track the numbers specific to ArriVent BioPharma's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?